期刊文献+

血管紧张素转换酶基因多态性对血浆血管紧张素Ⅱ水平及心衰的影响 被引量:5

Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin Ⅱ levels and the risk of chronic heart failure
下载PDF
导出
摘要 目的 :探讨血管紧张素转换酶 (ACE)D/I基因多态性对中国人血浆血管紧张素Ⅱ (AngⅡ )水平的影响 ,以及是否可影响心衰的发生。方法 :用多聚酶链式反应对 1 81例受检者 (1 0 2例健康体检者、79例慢性心衰患者 )进行ACE基因分型 ,用放射免疫法测定其AngⅡ水平。结果 :在 1 81例受检者中 ,ACE基因多态性与AngⅡ水平有关 ,AngⅡ水平依次为DD型 >ID型 >II型 (P <0 .0 5 )。多元逐步回归模型分析表明 ,校正多种混淆因素后AngⅡ水平仍受ACE基因型影响。ACE基因型在心衰患者和健康对照者中的分布无明显差异。结论 :国人ACED/I基因多态性与AngⅡ水平存在相关 ,携带DD型ACE基因者AngⅡ水平较高 ; Objective To investigate the effect of the polymorphism of angiotensin converting enzyme (ACE) gene D/I on the plasma angiotensin Ⅱ levels and the risk of chronic heart failure.Methods The genotype was determined by polymerase chain reaction (PCR) in 181 subjects (102 controls and 79 patients with chronic heart failure). The levels of plasma Ang Ⅱwere also assessed by radio immunity assay (RIA) in the above subjects.Results A marked difference in the plasma AngⅡ levels was observed among the 3 genotypes(DD,ID and II). The levels of plasma AngⅡ in DD genotype class were the highest [DD: (65.43± 26.68 ),ID: (55.49±25.90),II: (46.69±23.00); P <0.05, DD vs ID; P <0.01, DD vs II].The ACE gene I/D polymorphism showed that the levels of Ang Ⅱ were still affected by the ACE genotype after correcting confounding multifactor by linear regression analysis. There was no difference in genotypes or allele frequencies between the patients and the controls in our study. Conclusion The polymorphism of ACE gene D/I is associated with higher plasma AngⅡ levels in the Chinese. No evidence supports an association between ACE genotype and the diagnosis of chronic heart failure.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第2期198-200,共3页 Journal of Central South University :Medical Science
基金 湖南省科技厅基金资助 (0 3SSY40 1 7)
关键词 血管紧张素转换酶 基因多态性 血管紧张素Ⅱ 心力衰竭 放射免疫法 基因分型 heart failure,chronic peptidyl dipeptidase A gene polymorphism
  • 相关文献

参考文献13

  • 1Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion / deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels [J]. J Clin Invest, 1990, 86(4): 1343-1346.
  • 2Danser AHJ, Schalekamp MADH, Box WA, et al. Angiotensin-converrting enzyme in the human heart: effect of the deletion / insertion polymorphism [J]. Circulation, 1995,92 (6): 1387-1388
  • 3Tiret L, Mallet C, Poirer O, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the cardigene study [J]. J Am Coll Cardiol, 2000, 35 (1): 29-35.
  • 4McNamara DM, Holubkov R, Janosko K, et al. Pharmacogenetic interactions between β-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure [J]. Circulation, 2001, 103(12): 1644-1648.
  • 5Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion / deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1) [J]. Nucleic Acids Res, 1992, 20(6): 1433.
  • 6Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease [J]. N Engl J Med, 1995, 332(11): 706-711.
  • 7Candy GP, Skudicky D, Mueller U, et al. Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy [J]. Am J Cardiol, 1999,83 (5): 740-744.
  • 8Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction [J]. Nature, 1992, 359(6396): 641-644.
  • 9Shunckert H, Hense HW, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy [J]. N Engl J Med, 1994, 330(23): 1634-1638.
  • 10McNamara DM, Holubkov R, Janosko K, et al. Pharmacogenetic interactions between β-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure [J]. Circulation, 2001,103(12): 1644-1648.

二级参考文献1

  • 1杨林 叶任高.血管紧张素转移酶抑制药在肾脏病的应用[J].新医学,1999,30(7):420-421.

共引文献2

同被引文献72

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部